logo

Liquidia Technologies Inc. (LQDA)



Trade LQDA now with
  Date
  Headline
6/20/2022 7:07:43 AM Liquidia Names Rajeev Saggar Chief Medical Officer
3/1/2022 6:27:05 AM Pathalys Pharma Acquires License To EA Pharma's Upacicalcet Worldwide Outside Of Japan And Asia
6/7/2021 6:02:22 AM United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia
4/13/2021 7:16:30 AM Liquidia Enters Common Stock Purchase Deal For Private Placement Of 8.63 Mln Shares At $2.52/Shr
3/26/2019 6:56:50 AM Wedbush Is Raising Liquidia Technologies Inc. (LQDA) FY20 Estimate To -2.30 From -2.44
3/26/2019 6:56:33 AM Wedbush Is Increasing Liquidia Technologies Inc. (LQDA) Q4 20 Estimate To -0.67 From -0.83
3/26/2019 6:56:19 AM Wedbush Is Cutting Liquidia Technologies Inc. (LQDA) Q3 20 Estimate To -0.62 From -0.61
3/26/2019 6:56:01 AM Wedbush Is Increasing Liquidia Technologies Inc. (LQDA) FY19 Estimate To -1.85 From -2.09
3/26/2019 6:55:49 AM Wedbush Is Raising Liquidia Technologies Inc. (LQDA) Q3 19 Estimate To -0.46 From -0.55
3/26/2019 6:55:35 AM Wedbush Is Raising Liquidia Technologies Inc. (LQDA) Q2 19 Estimate To -0.46 From -0.54
3/26/2019 6:55:24 AM Wedbush Is Raising Liquidia Technologies Inc. (LQDA) Q1 19 Estimate To -0.45 From -0.54
3/26/2019 6:54:36 AM Wedbush Reiterates Liquidia Technologies Inc. (LQDA) At Outperform With $49 Up From $48 Price Target
3/12/2019 6:35:46 AM Wedbush Reiterates Liquidia Technologies Inc. (LQDA) At Outperform With $48 Up From $47 Price Target